# Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

> **NCT01510522** · PHASE4 · WITHDRAWN · sponsor: **Merck KGaA, Darmstadt, Germany**

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Glucophage
- **DRUG:** Glucophage

## Key facts

- **NCT ID:** NCT01510522
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510522, "Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01510522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*